Reducing unnecessary tests before low-risk surgeries
Official title: De-implementation of Low-Value Testing in Patients Undergoing Low-Risk Surgery
Funded at University of Michigan at Ann Arbor · NIH-10916512 · Data updated 2026-11-12
This study is looking to make surgery easier and safer for patients by cutting out unnecessary tests before low-risk surgeries, so you can have a smoother experience without extra costs or complications.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $373,189 |
| NIH project number | 5R01HS029306-02 |
| Project ID | NIH-10916512 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients scheduled for low-risk surgeries who may be subjected to unnecessary preoperative testing.
✕Less likely to help
Patients undergoing high-risk surgeries or those with complex medical conditions may not benefit from this research.
What this research studies
This research aims to eliminate unnecessary preoperative tests for patients undergoing low-risk surgeries, which have been shown to provide no benefit and can lead to additional complications and costs. By implementing a comprehensive strategy across multiple hospitals, the study seeks to reduce the prevalence of these low-value tests. The approach involves collaboration with a consortium of hospitals to ensure that the findings can be applied broadly and effectively. Patients will benefit from a streamlined surgical process that minimizes unnecessary testing and associated risks.
Why it matters
Potential benefit: If successful, this research could lead to safer surgical experiences and reduced healthcare costs for patients.
How similar studies have gone: Previous research has highlighted the prevalence of unnecessary testing, but this approach aims to implement a novel, scalable solution that has not been widely tested.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Dossett, Lesly a — University of Michigan at Ann Arbor
- Study coordinator: Dossett, Lesly a
Related research
Other NIH-funded projects on the same topics.
-
Expanding genetic testing for cancer risk in patients and families
This study is working to make it easier for cancer patients in Michigan to get genetic testing for cancer risk by improving how doctors gather family history and assess genetic risks, so that more people can receive the important evaluations they need.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Why the retina can sometimes heal itself and how we might help it heal
This NIH grant explores how inflammation and neural cells interact in the zebrafish retina to understand retinal neuron death and regeneration, with potential implications for human vision.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
Understanding how work exposures and genes influence ALS risk
A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.